DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Artificial Tears Market Analysis: by Type (Cellulose-Derived Tears, Glycerin-Derived Tears, Polyethylene Glycol and Propylene Glycol-Based Tears, Oil-Based Emulsion Tears and Others by End-User Age Group with Forecast (2016-2021)" report to their offering.
While artificial tears are easily available, over-the-counter remedies for DES, the use of artificial tears also has side effects that need to be kept in mind. Also, with some patients who require the use of artificial tears several times a day, regular artificial tears are not a good option. Technological advances associated with several years of research and development have addressed this issue with preservative-free artificial tears.
While the growth potential in regions such as Europe and North America still exist, the opportunities in developing economies in South America and APAC are poised to grow at higher rates comparatively. In Europe, an increasing ageing population is one aspect that will enhance the growth of the market. Changing lifestyles resulting in an increasing number of DES patients coupled with the increasing spending power of the population in these regions is expected to drive the growth of the artificial tears market in South America and Asia Pacific.
- Bausch + Lomb
- Abott Medical Optics, Inc.
- Johnson and Johnson
- Novartis International AG
- Allergan, Inc.
- Akorn, Inc.
- Santen Pharmaceuticals
- Novagali Pharma S.A.
- Alcon, Inc.
1. Artificial Tears - Market Overview
2. Executive Summary
3. Artificial Tears - Market Landscape
4. Artificial Tears - Market Forces
5. Artificial Tears Market - Strategic Analysis
6. Artificial Tears Market - By Type:
7. Artificial Tears Market - By End-user Age Group:
8. Artificial Tears Market - By Geography:
9. Artificial Tears Market - Market Entropy
10. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/2zk4rd/artificial_tears.